Stocks in Action: RWE, Fresenius Medical Care, Renk, Fielmann, Bilfinger
Reading Time: 4 minutes
Stock 1.) RWE - Energy provider benefits from prospects of economic recovery, JPMorgan places on Positive Catalyst Watch, maintains Overweight rating with a target price of €47.50. A notable buy rating from JPMorgan is attracting attention to RWE on Tuesday. The rating was confirmed as "Overweight" with a target price of €47.50. Analysts expect positive news regarding capital utilization upon the release of quarterly results. They see room for investment reductions of between €3 billion and €5 billion, which could open the door for further...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
